Increase of opioid μ-receptor gene expression in streptozotocin-induced diabetic rats

Hormone and Metabolic Research

Volumn 33, Issue 8, 2001, Pages 467-471

  Cheng, J T ^a   Liu, I M ^a   Chi, T C ^a   Tzeng, T F ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Diabetic Rats; Insulin Opioid Receptor; Phlorizin

Indexed keywords

GLUCOSE; INSULIN; LOPERAMIDE; MU OPIATE RECEPTOR; OPIATE; PHLORIZIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNOBLOTTING; INSULIN DEFICIENCY; KNOCKOUT MOUSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HYPERGLYCEMIA; INJECTIONS, INTRAVENOUS; INSULIN; LOPERAMIDE; MALE; MICE; MICE, KNOCKOUT; NARCOTICS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; RNA, MESSENGER; STREPTOZOCIN;

ANIMALIA;

EID: 0034836657     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16939     Document Type: Article

References (22)

1. The regulation of insulin and glucagon secretion by opiates: A study with naloxone in healthy humans
2. The occurrence and receptor specificity of endogenous opioid peptides with pancreas and liver of the rat. Comparison with brain
3. Stimulation by beta-endorphins (1-27 & 1-31)
4. Investigations of the mechanism of the reduction of plasma glucose by cold-stress in streptozotocin-induced diabetic rats
5. Activation of opioid μ-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats
6. Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle
7. An insulin-dependent hypoglycemia induced by electroacupuncture at the Zhongwan (CV12) acupoint in diabetic rats
8. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity
9. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist-loperamide
10. μ opioid receptor knockout in mice: Effects on ligand-induced analgesia and morphine lethality
11. Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes
12. Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin
13. Hepatic metabolism of genetically diabetic (db/db) mice. I. Carbohydrate metabolism
14. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats
15. The influence of high sugar consumption by mice on the duration of action of barbiturates and in vivo metabolism of barbiturates, aniline and p-nitroanisole
16. Effects of glucose on enzyme activity and duration of drug action
17. Effects of streptozotocin-induced diabetes on feeding stimulated by centrally administered opioid agonists
18. Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine
19. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists
20. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy
21. Drug abuse: Hedonic homeostatic dysregulation
22. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons